πŸ‡ΊπŸ‡Έ FDA
Patent

US 10407403

Preparation method of cobimetinib

granted A61KA61K31/4523A61P

Quick answer

US patent 10407403 (Preparation method of cobimetinib) held by Suzhou Miracpharma Technology Co., Ltd. expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Suzhou Miracpharma Technology Co., Ltd.
Grant date
Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/4523, A61P, A61P35/00